Learn more

PLIVA-ISTRAŽIVAEKI INSTITUT D.O.O.

Overview
  • Total Patents
    17
About

PLIVA-ISTRAŽIVAEKI INSTITUT D.O.O. has a total of 17 patent applications. Its first patent ever was published in 2002. It filed its patents most often in Croatia. Its main competitors in its focus markets pharmaceuticals and organic fine chemistry are GLAXOSMITHKLINE ZAGREB, FEUERBACH DOMINIK and AMNESTIX INC.

Patent filings in countries

World map showing PLIVA-ISTRAŽIVAEKI INSTITUT D.O.O.s patent filings in countries
# Country Total Patents
#1 Croatia 17

Patent filings per year

Chart showing PLIVA-ISTRAŽIVAEKI INSTITUT D.O.O.s patent filings per year from 1900 to 2020

Focus industries

Top inventors

# Name Total Patents
#1 Mercep Mladen 12
#2 Mesic Milan 12
#3 Peueic Dijana 8
#4 Hrvaeic Boueka 5
#5 Rupeic Renata 3
#6 Eimieic Lidija 3
#7 Malnar Ivica 3
#8 Markovic Stribor 3
#9 Elenkov Ivaylo Jivkov 3
#10 Klonkay Andreja Eempuh 2

Latest patents

Publication Filing date Title
HRP20040318A2 Furochromen derivative with anti-inflammaroty activity
HRP20040104A2 Use of benzonaphthoazulenes for the manufacture of pharmaceutical formulations for the treatment and prevention of central nervous system diseases and disorders
HRP20030955A2 USE OF 1-OXADIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030957A2 USE OF 1-THIA-3-AZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030953A2 PREPARATION OF 1-AZA-2-OXA-DIBENZO[e,h]AZULENES AND THEIR USE FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030956A2 USE OF 1,2-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANU
HRP20030958A2 USE OF 1,3-DIAZA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYSTEM DISEASES AND DISORDERS
HRP20030914A2 METHOD OF PREPARATION OF [2-(11-CHLOR-8-OXA-1-THIA-DIBENZO[e,h]AZULEN-2-ILMETOXI)-ETHYL]-DIMETHYL-AMINES AND SALTS THEREOF
HRP20030885A2 USE OF 2-THIA-DIBENZO[e,h]AZULENES FOR THE MANUFACTURE OF PHARMACEUTICAL FORMULATIONS FOR THE TREATMENT AND PREVENTION OF CENTRAL NERVOUS SYYTEM DISEASES AND DISORDERS
HRP20030603A2 Substituted furochromene compounds of antiinflammatory action
HRP20030604A2 Substituted furochromenes, preparation thereof andtheir antiinflammatory action
HRP20030324A2 Compounds of antiinflammatory effect
HRP20030160A2 1-thiadibenzoazulene derivatives and biological action thereof
HRP20020991A2 N"-Substituted 9a-N-(N'-carbamoyl-Gamma-aminopropyl), 9a-N-(N'? -thiocarbamoyl-Gamma-aminopropyl), 9a-N-(N'-((Beta-cyanoethyl)-N'-carbamoyl-Gamma? -aminopropyl) and 9a-N-(N'-(Beta-cyanoethyl)-N'-thiocarbamoyl-Gamma? -aminopropyl) derivatives of 9-de
HRP20020886A2 SUBSTITUTED 9a-N-[N'-(BENZENSULFONYL)CARBAMOYL-γ-AMINOPROPYL) AND 9a-N(N' -(?-CYANOETHIL)-N' -(b
HRP20020779A2 NEW 3-DECLADINOSYL DERIVATIVES OF 9-DEOXO-9-DIHYDRO-9a-AZA-9a-HOMOERYTHROMICIN A 9a, 11-CYCLIC CARBAMATES